Skip to main content

Brompheniramine Maleate, Pseudoephedrine Hydrochloride and Dextromethorphan Hydrobromide

NDC 50090-5625 · A-S Medication Solutions

Generic nameBrompheniramine Maleate, Pseudoephedrine Hydrochloride and Dextromethorphan Hydrobromide
Dosage formSYRUP
RouteORAL
Active ingredient(s)BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE, DEXTROMETHORPHAN HYDROBROMIDE
Strength2; 10; 30 mg/5mL; mg/5mL; mg/5mL
Pharmacologic classAdrenergic alpha-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-Adrenergic Agonist [EPC]
Marketing categoryANDA

Packages

50090-5625-0 — 118 mL in 1 BOTTLE, PLASTIC (50090-5625-0)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

50090-1077 — Guaifenesin and Dextromethorphan Hydrobromide, 50090-1078 — Guaifenesin and Dextromethorphan Hydrobromide, 50090-1203 — fexofenadine hydrochloride and pseudoephedrine hydrochloride, 50090-1961 — Pseudoephedrine HCl, 50090-4345 — Pseudoephedrine HCl, 50090-4546 — Pseudoephedrine Hydrochloride, 50090-4629 — Pseudoephedrine Hydrochloride, 50090-5534 — chlorpheniramine maleate, dextromethorphan hydrochloride, 50090-5554 — Pseudoephedrine hydrochloride, 50090-5615 — Pseudoephedrine HCl, 50090-6020 — Guaifenesin, Dextromethorphan HBr, 50090-6467 — promethazine hydrochloride and dextromethorphan hydrobromide, 50090-6549 — Guaifenesin and Dextromethorphan Hydrobromide, 50090-6585 — Promethazine Hydrochloride and Dextromethorphan Hydrobromide Oral, 50090-6747 — dextromethorphan hydrobromide, guaifenesin, 50090-6755 — Promethazine Hydrochloride and Dextromethorphan Hydrobromide, 50090-7085 — Pseudoephedrine HCl, Triprolidine HCl, 50090-7257 — dextromethorphan hydrobromide, guaifenesin, 50090-7258 — dextromethorphan HBr, guaifenesin, 50090-7658 — Promethazine Hydrochloride and Dextromethorphan Hydrobromide, +2244 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels